BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33194646)

  • 21. Genetic and molecular alterations across medulloblastoma subgroups.
    Skowron P; Ramaswamy V; Taylor MD
    J Mol Med (Berl); 2015 Oct; 93(10):1075-84. PubMed ID: 26350064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic testing and tumor surveillance for children with cancer predisposition syndromes.
    Rao A; Rothman J; Nichols KE
    Curr Opin Pediatr; 2008 Feb; 20(1):1-7. PubMed ID: 18197032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular variants and mutations in medulloblastoma.
    Schroeder K; Gururangan S
    Pharmgenomics Pers Med; 2014; 7():43-51. PubMed ID: 24523595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a.
    Holsten T; Tsiakas K; Kordes U; Bison B; Pietsch T; Rutkowski S; Santer R; Schüller U
    Childs Nerv Syst; 2018 Mar; 34(3):581-584. PubMed ID: 29167993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial medulloblastoma: case report of one family and review of the literature.
    von Koch CS; Gulati M; Aldape K; Berger MS
    Neurosurgery; 2002 Jul; 51(1):227-33; discussion 233. PubMed ID: 12182422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Childhood medulloblastoma].
    Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
    Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medulloblastoma in the age of molecular subgroups: a review.
    Juraschka K; Taylor MD
    J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic predisposition to endocrine tumors: Diagnosis, surveillance and challenges in care.
    Petr EJ; Else T
    Semin Oncol; 2016 Oct; 43(5):582-590. PubMed ID: 27899191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predisposition to pediatric and hematologic cancers: a moving target.
    Malkin D; Nichols KE; Zelley K; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial Gastric Cancers.
    Setia N; Clark JW; Duda DG; Hong TS; Kwak EL; Mullen JT; Lauwers GY
    Oncologist; 2015 Dec; 20(12):1365-77. PubMed ID: 26424758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncovering Hereditary Tumor Syndromes: Emerging Role of Surgical Pathology.
    Agaimy A; Hartmann A
    Semin Diagn Pathol; 2018 May; 35(3):154-160. PubMed ID: 29395463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical management of hereditary colorectal cancer syndromes.
    Half EE; Bresalier RS
    Curr Opin Gastroenterol; 2004 Jan; 20(1):32-42. PubMed ID: 15703618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Predisposition to Solid Pediatric Cancers.
    Capasso M; Montella A; Tirelli M; Maiorino T; Cantalupo S; Iolascon A
    Front Oncol; 2020; 10():590033. PubMed ID: 33194750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience.
    Desai AV; Perpich M; Godley LA
    Front Pediatr; 2017; 5():252. PubMed ID: 29270394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
    Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
    Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wilms tumor, medulloblastoma, and rhabdomyosarcoma in adult patients: lessons learned from the pediatric experience.
    Spreafico F; Ferrari A; Mascarin M; Collini P; Morosi C; Biasoni D; Biassoni V; Schiavello E; Gandola L; Gattuso G; Chiaravalli S; Massimino M
    Cancer Metastasis Rev; 2019 Dec; 38(4):683-694. PubMed ID: 31797181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gynaecological neoplasms in common familial syndromes (Lynch and HBOC).
    Bartosch C; Clarke B; Bosse T
    Pathology; 2018 Feb; 50(2):222-237. PubMed ID: 29287922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective family study of childhood medulloblastoma.
    Ng D; Stavrou T; Liu L; Taylor MD; Gold B; Dean M; Kelley MJ; Dubovsky EC; Vezina G; Nicholson HS; Byrne J; Rutka JT; Hogg D; Reaman GH; Goldstein AM
    Am J Med Genet A; 2005 May; 134(4):399-403. PubMed ID: 15759260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nervous system tumors associated with familial tumor syndromes.
    Ohgaki H; Kim YH; Steinbach JP
    Curr Opin Neurol; 2010 Dec; 23(6):583-91. PubMed ID: 21042217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.